SCHEMBL14014133

SCHEMBL14014133

COOSc1ncc2cc(Oc3ccccc3F)c(=O)n(C3CC3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 9/20 0.49
MAPK8 P45983 5/20 0.40
CYP1A2 P05177 7/20 0.39
ALDH1A1 P00352 6/20 0.39
CYP2C9 P11712 5/20 0.39
MAPK1 P28482 4/20 0.39
USP2 O75604 4/20 0.39
GAK O14976 1/20 0.39
RPS6KA4 O75676 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
MAPK9 P45984 1/20 0.39
CSNK1D P48730 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MAPK10 P53779 1/20 0.39
DDR1 Q08345 1/20 0.39
MAPK11 Q15759 1/20 0.39
TAOK1 Q7L7X3 1/20 0.39
COQ8A Q8NI60 1/20 0.39
PRKD2 Q9BZL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4173536 0.88 MAPK14 (0.52) MAPK14MAPK8CYP1A2ALDH1A1CYP2C9
SCHEMBL14014081 0.85 MAPK14 (0.55) MAPK14MAPK8MAPK1GAKRPS6KA4
SCHEMBL14014142 0.82 MAPK14 (0.41) MAPK14MAPK8CYP1A2ALDH1A1MAPK1
SCHEMBL14038840 0.81 MAPK14 (0.55) MAPK14MAPK8CYP1A2ALDH1A1CYP2C9
SCHEMBL4171237 0.80 MAPK14 (0.51) MAPK14MAPK8CYP1A2ALDH1A1CYP2C9
SCHEMBL14014097 0.77 MAPK14 (0.65) MAPK14MAPK8MAPK1GAKRPS6KA4
SCHEMBL14014092 0.75 MAPK14 (0.45) MAPK14MAPK8MAPK1GAKRPS6KA4
SCHEMBL4186016 0.73 MAPK14 (0.56) MAPK14MAPK8MAPK1GAKRPS6KA4
SCHEMBL14014103 0.73 MAPK8 (0.49) MAPK14MAPK8MAPK1GAKRPS6KA4
SCHEMBL29594724 0.73 MAPK14 (0.75) MAPK14MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449581-B2 6-Substituted pyrido-pyrimidines POCHE PALO ALTO LLC (US) 2008-11-11 US disclosed
US-20070135458-A1 6-Substituted pyrido-pyrimidines CHEN JIAN J 2007-06-14 US disclosed
US-7169794-B2 6-substituted pyrido-pyrimidines ROCHE PALO ALTO LLC (US) 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135458-A1 6-Substituted pyrido-pyrimidines P2RX6, P2RX1, P2RX7 MAPK14 4250/4885MAPK8 3523/4885CYP1A2 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.